ArticleIJID regions2025
No evidence of hepatitis E virus-associated central nervous system infections in a Vietnamese multicenter cohort.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Extra-Hepatic Manifestations of Hepatitis E Virus (HEV): A Narrative Review on Meningoencephalitis.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Hepatitis E virus (HEV), traditionally associated with acute hepatitis, has been increasingly recognized as a potential cause of neurological disease, particularly in Europe and parts of Asia. However, its role in central nervous system (CNS) infections in Vietnam has not been investigated. Methods: We retrospectively analyzed cerebrospinal fluid (CSF) samples from 330 patients hospitalized with suspected CNS infections at four tertiary hospitals in Northern Vietnam. Extensive diagnostics, including CSF culture, multiplex polymerase chain reaction (PCR), customized PCR assays, and 16S nanopore sequencing, identified a pathogen in 27% of cases. All samples were additionally screened for HEV RNA using nested PCR targeting the ORF1 region. Results: No HEV RNA was detected in this study. In our previous investigations, the most common pathogens identified were Conclusions: Given evidence of HEV genotype 3 circulation in Vietnam, future prospective studies combining molecular and serological approaches are warranted to clarify the potential contribution of HEV to neurological disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.